Editorial: Of mind and matter — or what really matters in Alzheimer's disease? Hans Förstl Neurobiological Substrates of Clinical Deficits in Alzheimer's Disease Pages: 116 - 117
The molecular significance of amyloid β-peptide for Alzheimer's disease Christian Haass Neurobiological Substrates of Clinical Deficits in Alzheimer's Disease Pages: 118 - 123
Inflammatory mechanisms in Alzheimer's disease M. HüllM. BergerB. Volk Neurobiological Substrates of Clinical Deficits in Alzheimer's Disease Pages: 124 - 128
Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease W. F. GattazH. FörstlR. Levy Neurobiological Substrates of Clinical Deficits in Alzheimer's Disease Pages: 129 - 131
The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample H. -J. GertzH. KrügerW. O'Connor Neurobiological Substrates of Clinical Deficits in Alzheimer's Disease Pages: 132 - 136
Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia C. BancherK. JellingerF. Leblhuber Neurobiological Substrates of Clinical Deficits in Alzheimer's Disease Pages: 137 - 146
Diagnostic validity of basic symptoms Joachim KlosterkötterHermann EbelEckhard Michael Steinmeyer Original Paper Pages: 147 - 154
The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy Here Folkerts Original Paper Pages: 155 - 164
Facial affect recognition in the course of schizophrenia W. WölwerM. StreitU. Polzer Original Paper Pages: 165 - 170
Psychiatric epidemiology cross-cultural perspective: a review Yekeen A. AderibigbeAdityanjee Erratum Pages: 171 - 171
